At Planful Perform25, Lyre’s CFO Ross Aird delivered a candid account of moving from spreadsheet chaos to structured ...

Good news for Allecra Therapeutics as FDA approves its Exblifep antibiotic for complicated UTIs, but a rival therapy from Venatorx and Melinta is rejected.

Regeneron's Ordspono (odronextamab) for non-Hodgin lymphoma (NHL) is cleared in EU five months after being turned down by the FDA ...